Navigation Links
PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
Date:11/4/2010

ANNAPOLIS, Md., Nov. 4, 2010 /PRNewswire-FirstCall/ -- PharmAthene, Inc. (NYSE Amex: PIP), a biodefense company developing medical countermeasures against biological and chemical threats, announced today that the Company was awarded four separate grants totaling approximately $850,000 under the Qualifying Therapeutic Discovery Project, enacted as part of the Patient Protection and Affordable Care Act of 2010 (P.L. 111-148). The grant is a benefit targeted to small business therapeutic discovery projects that show a potential to result in new therapies to treat areas of unmet medical need or prevent, detect or treat chronic or acute diseases and conditions.

"We are delighted that PharmAthene was selected as a grant recipient under this program," commented Eric I. Richman, President and Chief Executive Officer.  The Therapeutic Discovery initiative was established to promote the research and development of biomedical programs that show significant potential to produce new and cost-saving therapies, support quality job creation, and increase U.S. competitiveness.  Since its inception, PharmAthene has focused on developing urgently needed, best-in-class, next generation medical countermeasures that offer the potential for improved safety, convenience, and cost-effectiveness, consistent with this imperative.  We look forward to advancing our mission and remain committed to meeting the needs of the U.S. government to ensure the safety and well-being of Americans at home and on the battlefield."

About PharmAthene, Inc.

PharmAthene was formed to meet the critical needs of the United States and its allies by developing and commercializing medical countermeasures against biological and chemical weapons. PharmAthene's lead product development programs include:

  • SparVax™ - a second generation recombinant pr
    '/>"/>

SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Announces Pricing of $15 Million Public Offering
2. PharmAthene Announces Proposed Common Stock Offering
3. PharmAthene Announces $3.9 Million Registered Direct Offering
4. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
5. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
6. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
7. PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
8. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
9. PharmAthene to Present at the 2010 Roth Capital Markets Growth Stock Conference on Monday, March 15, 2010
10. PharmAthene Submits White Paper to BARDA for Advanced Development Funding for SparVax(TM) - Novel Recombinant Protective Antigen Anthrax Vaccine
11. PharmAthene Appoints Jeffrey W. Runge, M.D. to the Companys Board of Directors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/30/2015)... ... June 30, 2015 , ... ... does not sacrifice selectivity to achieve faster flow rates in comparison to nylon ... with significant open space to allow easy liquid flow while trapping particulates as ...
(Date:6/30/2015)...  The University of California, San Diego,s Center ... San Diego Extension announced their third annual workshop ... – 14, 2015, at UC San Diego (see ... intense exposure to best practices and the latest ... biologists, process engineers and business executives planning next ...
(Date:6/30/2015)... ... June 30, 2015 , ... Southern ... accepted the position of vice president of instruction at Chippewa Valley Technical College ... greatly appreciated the opportunity to lead SIUE during the past three years,” Furst-Bowe ...
(Date:6/29/2015)... 30, 2015   Pharnext SAS today announced that ... the treatment of Charcot-Marie-Tooth Type 1A (CMT1A), is being presented ... Peripheral Nerve Society (PNS) Biennial Meeting at the Quebec Congress ... 27 - July 2, 2015. At Poster Viewing ... 1, 5p.m. to 7p.m. EDT: Poster 23: ...
Breaking Biology Technology:New Nanofiber Membrane Provides Fast, Efficient Filtration 2UC San Diego Extension to Offer Third Annual Microbial Fermentation Workshop 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 2SIUE’s Furst-Bowe Accepts VP of Instruction at CVTC 3Pharnext's PXT-3003 Featured in Multiple Presentations at 2015 Peripheral Nerve Society Biennial Meeting 2
... Citing one-time gains due to Hurricane Katrina and other Gulf ... a net loss of nearly $45 million, or 20 cents ... information management services firm reported net income of $105.9 million, ... of 2005, a drop of 29.6 percent. , ,The decrease ...
... visit to the Menomonee Valley, Gov. Jim Doyle ... state budget for the new Wisconsin Venture Center. , ,Doyle ... that will connect entrepreneurs with sources of capital, and serve ... in Wisconsin. , ,The concept was announced in December of ...
... most spending proposals, the devil is in the details and ... Jim Doyle's new Grow Milwaukee package contains several initiatives ... ,The package, which Doyle alluded to in last week's ... economic development, healthcare, and education proposals designed to build on ...
Cached Biology Technology:Doyle proposes $2M for venture capital center 2Grow Milwaukee includes millions for tech funding 2Grow Milwaukee includes millions for tech funding 3
(Date:6/24/2015)... -- The biologics safety testing market is growing at ... include growth of the pharmaceutical and biological industries and ... years, the number of drug approvals in North American ... approved 225 drug applications and Health Canada approved 99. ... accounted for 3,822 of the pharmaceutical and 1,998 ...
(Date:6/24/2015)... June 24, 2015  Synaptics Inc. (NASDAQ: ... solutions, today announced that Sharp has selected its ... authentication for its latest flagship smartphone device, the ... 200 million shipments of its fingerprint ID sensor ... strength, scalability and leadership in the biometrics market ...
(Date:6/24/2015)... Biometry authentication provider KeyLemon today announced ... one face in. Logo - ... in, entering the expanding biometric authentication market in ... answer to the password problem. With advanced face ... KeyLemon, one face in allows users to securely ...
Breaking Biology News(10 mins):Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2KeyLemon Announces Partnership With Biometric Password Solution onefacein 2
... a 12-year action plan calling for reducing the hypoxia zone ... and there is no evidence that nutrient loading to the ... have identified some of the biophysical and social barriers to ... that a partnership of researchers work closely with farmers to ...
... N.H. A grant to the University of New ... biologists identify an abundant yet largely unknown category of ... functions they play. The National Science Foundation awarded ... Network on eukaryotic biodiversity. The work will apply new ...
... Md. (Nov. 7, 2013)Chronic obstructive pulmonary diseasea health problem ... it progressively harder to breathecan have a dramatic effect ... activities of daily life because of the disease,s fallout ... in these muscle problems. These include loss of fitness ...
Cached Biology News:Researchers suggest plan to address hypoxia in Gulf of Mexico 2Researchers suggest plan to address hypoxia in Gulf of Mexico 3UNH, UC Davis launch network to study environmental microbes 2Vitamin C could ease muscle fatigue in chronic obstructive pulmonary disease patients 2
... S-X media are neutral, porous ... exclusion chromatography of lipophilic polymers ... organic eluents. The beads are ... carbon tetrachloride, dimethylformamide, ketones, aromatics, ...
... Anti-GSTM1 Monoclonal Antibody Epitope: ... [Schistosoma japonicum]. Recommended Storage: ... Aliquot contents and freeze at -20 C ... of freezing and thawing. Centrifuge product if ...
Mouse monoclonal [HYB 232-02] to Protein S ( Abpromise for all tested applications). entrezGeneID: 5627 SwissProtID: P07225...
... unique aptamer microarray services using a ... and sequence design software to suit ... screening of aptamers as drug candidates. ... sequence design, synthesis of standard or ...
Biology Products: